tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

IMAB Stock Latest News

I-Mab Announces Major Leadership Overhaul
Company AnnouncementsI-Mab Announces Major Leadership Overhaul
3d ago
6K
IMAB
I-Mab announces leadership transitions
PremiumThe Fly
I-Mab announces leadership transitions
3d ago
IMAB
I-Mab Biopharma: Innovating Cancer Treatments
PremiumCompany Announcements
I-Mab Biopharma: Innovating Cancer Treatments
1M ago
6K
IMAB
I-Mab names Phillip Dennis, MD, PhD, as Chief Medical Officer
PremiumThe Fly
I-Mab names Phillip Dennis, MD, PhD, as Chief Medical Officer
1M ago
SNY
IMAB
I-Mab and Bristol Myers Squibb Tackle Gastric Cancer
PremiumCompany Announcements
I-Mab and Bristol Myers Squibb Tackle Gastric Cancer
1M ago
6K
IMAB
I-Mab announces clinical trial collaboration with Bristol Myers
PremiumThe FlyI-Mab announces clinical trial collaboration with Bristol Myers
1M ago
BMY
IMAB
I-Mab’s Ragistomig Shows Promise in Phase 1 Trials
PremiumCompany Announcements
I-Mab’s Ragistomig Shows Promise in Phase 1 Trials
2M ago
6K
IMAB
I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024
PremiumPress Releases
I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024
2M ago
IMAB
Patent Law Changes Pose Threat to I-Mab Adr’s Drug Candidate Protection
PremiumCompany Announcements
Patent Law Changes Pose Threat to I-Mab Adr’s Drug Candidate Protection
3M ago
IMAB
I-Mab Announces CMO Transition, Interim Successor Named
PremiumCompany Announcements
I-Mab Announces CMO Transition, Interim Successor Named
3M ago
6K
IMAB
I-Mab Finalizes Divestiture and Resolves Obligations
PremiumCompany Announcements
I-Mab Finalizes Divestiture and Resolves Obligations
4M ago
6K
IMAB
I-Mab Announces Major Leadership Reshuffle
PremiumCompany Announcements
I-Mab Announces Major Leadership Reshuffle
4M ago
6K
IMAB
I-Mab price target lowered to $10 from $15 at Piper Sandler
PremiumThe FlyI-Mab price target lowered to $10 from $15 at Piper Sandler
4M ago
IMAB
I-Mab price target lowered to $8 from $18 at H.C. Wainwright
PremiumThe Fly
I-Mab price target lowered to $8 from $18 at H.C. Wainwright
4M ago
IMAB
I-Mab Reports Full Year 2023 Financial Results and Business Update
PremiumPress Releases
I-Mab Reports Full Year 2023 Financial Results and Business Update
4M ago
IMAB
I-Mab to divest assets, business operations in China fo $80M
PremiumThe Fly
I-Mab to divest assets, business operations in China fo $80M
5M ago
IMAB
I-Mab granted FDA Breakthrough Therapy Designation for felzartamab
PremiumThe Fly
I-Mab granted FDA Breakthrough Therapy Designation for felzartamab
9M ago
IMAB
Cantor biotech/biopharma analysts hold an analyst/industry conference call
PremiumThe Fly
Cantor biotech/biopharma analysts hold an analyst/industry conference call
9M ago
JNJ
AMAM
Cantor biotech/biopharma analysts hold an analyst/industry conference call
PremiumThe Fly
Cantor biotech/biopharma analysts hold an analyst/industry conference call
9M ago
JNJ
AMAM
Cantor biotech/biopharma analysts hold an analyst/industry conference call
PremiumThe FlyCantor biotech/biopharma analysts hold an analyst/industry conference call
9M ago
JNJ
AMAM
I-Mab provides update on TJ-L14B/ABL503 antibody developments
PremiumThe Fly
I-Mab provides update on TJ-L14B/ABL503 antibody developments
9M ago
IMAB
I-Mab price target lowered to $23 from $24 at Needham
PremiumThe Fly
I-Mab price target lowered to $23 from $24 at Needham
10M ago
ABBV
IMAB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >